A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DA / dopaminergic

[Related PubMed/MEDLINE]
Total Number of Papers: 1614
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DA  (>> Co-occurring Abbreviation)
Long Form:   dopaminergic
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Dopaminergic modulation of olfactory-evoked motor output in sea lampreys (Petromyzon marinus L.). OB
2020 Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. AAVs, GFAP, GLT-1, PD, PSD-95, shRNA, siRNAs, SNpc
2020 Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model. DAT, GFAP, Iba1, MPTP, NEIL1, PD, TH
2020 Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. nAChRs
2020 Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease. iPSCs, PD
2020 Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. HFD, LPS, ROT
2020 Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson's Disease and Diabetes. CCCP, HG, PD, ROS, TXNIP
2019 A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration. BMP, Gbb, LRRK2, pMad
2019 A test of dopamine hyper- and hyposensitivity in alcohol use. FRN
10  2019 AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease. alpha-syn-WT, GFP, PD, SNpc
11  2019 Activation of Peroxisome Proliferator-Activated Receptor-alpha Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons. Nurr1, PD, PPAR
12  2019 Acute Tramadol-Induced Cellular Tolerance and Dependence of Ventral Tegmental Area Dopaminergic Neurons: An In Vivo Electrophysiological Study. VTA
13  2019 Age-Associated Dopaminergic Neuron Loss and Midbrain Glia Cell Phenotypic Polarization. Arg1, BDNF, GDNF, IL-1beta, Lcn2, TNF-alpha
14  2019 Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. alpha-Syn, ClpP, PD, SOD2
15  2019 Alterations and adaptation of ventral tegmental area dopaminergic neurons in animal models of depression. VTA
16  2019 Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism. DA1, DMV, PD
17  2019 Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging. FC, VTA
18  2019 AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression. AMPK, pAMPK, PD, SNpc
19  2019 Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota. AQ, BU, BW, CT, EA, ET, PD
20  2019 Anticancer Drugs for Parkinson's Disease: Is It a Ray of Hope or Only Hype? PD
21  2019 Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity. DPSCs, GFAP, NO
22  2019 Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus. AREs, hPSCs, PD, PKC, SN
23  2019 Biochanin A protects against angiotensin II-induced damage of dopaminergic neurons in rats associated with the increased endophilin A2 expression. Ang II, AT1R, EPA2, GPCR
24  2019 Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease. GAP43, MPTP, PD, TH, VEGF
25  2019 Central Processing of Itch in the Midbrain Reward Center. GABA, VTA
26  2019 Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systems. ARC, CS, DAGL, DAT, EC, LH, PFC
27  2019 Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF. CRE, CREB, GDNF, PD, PKA, SNpc
28  2019 Cocaine Directly Inhibits alpha6-Containing Nicotinic Acetylcholine Receptors in Human SH-EP1 Cells and Mouse VTA DA Neurons. sIPSCs, VTA
29  2019 Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson's Disease. NHPs, PD, SNpc
30  2019 Comparison between dopaminergic and non-dopaminergic neurons in the VTA following chronic nicotine exposure during pregnancy. ECM, non-DA, VTA
31  2019 Conditional Haploinsufficiency of beta-Catenin Aggravates Neuronal Damage in a Paraquat-Based Mouse Model of Parkinson Disease. PD, PQ
32  2019 Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-kappaB signaling pathway. LPS, PD, TH
33  2019 Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease. MPTP, MQC, PD, SNpc
34  2019 Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway. GP, PD, VMAT2
35  2019 Differential effect of modafinil on impulsivity, attention and motor activity in preadolescent rats prenatally treated with alcohol. PA, PS
36  2019 Differentiation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells into Dopaminergic Neurons. CNS, DIFs, iPSCs, NSCs, PD
37  2019 DKK1 expression is suppressed by miR-9 during induced dopaminergic differentiation of human trabecular meshwork mesenchymal stem cells. TM-MSCs
38  2019 Dose-dependent effects of estrogen on prediction error related neural activity in the nucleus accumbens of healthy young women. NAc, PE
39  2019 Dysfunction of Cellular Proteostasis in Parkinson's Disease. alpha-Syn, ER, PD, UPR
40  2019 Echoes of Emotions Past: How Neuromodulators Determine What We Recollect. LC-NE, NE
41  2019 Effects of brief inhibition of the ventral tegmental area dopamine neurons on the cocaine seeking during abstinence. CS, TH, VTA
42  2019 Effects of Silibinin Against Prothrombin Kringle-2-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System In Vivo. PD, pKr-2
43  2019 Electrical Abnormalities in Dopaminergic Neurons of the Substantia Nigra in Mice With an Aromatic L-Amino Acid Decarboxylase Deficiency. AADC, AHP, APs, sEPSCs, sIPSCs, SNc
44  2019 Elevated dopamine signaling from ventral tegmental area to prefrontal cortical parvalbumin neurons drives conditioned inhibition. dmPFC, PV, SL, VTA
45  2019 Emergence of novel functions in striatal low-threshold spike interneurons. GLU, SPNs, top
46  2019 Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests newtherapeutic approaches. DAT, PD, PET, TH, TSPO
47  2019 EZH2 Is Essential for Fate Determination in the Mammalian Isthmic Area. cKOs, IsO, NPCs, PcGs, PRC2
48  2019 FGF-2 isoforms influence the development of dopaminergic neurons in the murine substantia nigra, but not anxiety-like behavior, stress susceptibility, or locomotor behavior. CNS, FGF-2, HMW, SNpc
49  2019 FoxO1 regulates leptin-induced mood behavior by targeting tyrosine hydroxylase. FOXO1, STAT3, TH
50  2019 Functional dopaminergic neurons derived from human chorionic mesenchymal stem cells ameliorate striatal atrophy and improve behavioral deficits in Parkinsonian rat model. HCMSCs, PD
51  2019 GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease. aSyn, dm, GBA, PD
52  2019 Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease. CNS, PD
53  2019 Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes. hSSCs, OEC-CM, PD
54  2019 Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies. iNSCs, PBMNCs, PD, SeV, SNpc, VM
55  2019 Gold nanoclusters for Parkinson's disease treatment. L-NIBC, PD, WB
56  2019 Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases. hESC, NO, PD
57  2019 Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease. BDNF, bFGF, FGF8, GDNF, OE-MSCs, PD, SHH
58  2019 Impact of Sleep-Wake-Associated Neuromodulators and Repetitive Low-Frequency Stimulation on Human iPSC-Derived Neurons. iPSC, LFS, LTD, SBFs
59  2019 Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease. AIH, EPM, NOR, PD, SI, SNc
60  2019 Induction of Tyrosine Hydroxylase Gene Expression in Embryonal Carcinoma Stem Cells Using a Natural Tissue-Specific Inducer. NRBE
61  2019 Inhibition of Ezh2 In Vitro and the Decline of Ezh2 in Developing Midbrain Promote Dopaminergic Neurons Differentiation Through Modifying H3K27me3. VM-NSCs
62  2019 Innate immune responses to paraquat exposure in a Drosophila model of Parkinson's disease. PD, PQ
63  2019 Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing. MSA, PD, SN
64  2019 Ketamine increases the expression of GluR1 and GluR2 alpha-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells. ---
65  2019 Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy. KO, PD, SNc
66  2019 Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson's disease. dR, mito-dR, PD
67  2019 Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of Parkinson's disease. dR, mito-dR, PD
68  2019 LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson's disease through RAB3IP. ceRNAs, PD, qRT-PCR, RIP
69  2019 Long non-coding RNA repertoire and open chromatin regions constitute midbrain dopaminergic neuron - specific molecular signatures. lncRNAs
70  2019 Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease. CREB, FMRP, FXS, ILBD, MMP9, PD, PKC, SNc
71  2019 Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer's Disease. AD, APO, EEGs, MC, SN, VTA
72  2019 Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. EOPD, PD
73  2019 LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients. GCase, PD
74  2019 MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling. Eya, GDNF, Six2
75  2019 Modeling Parkinson's disease in adult Drosophila. PD
76  2019 Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death. AD, MS
77  2019 NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation. NADPH, PD, ROS, SNpc
78  2019 Naringenin targets on astroglial Nrf2 to support dopaminergic neurons. NAR, Nrf2, PD
79  2019 NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable Substantia nigra Dopaminergic Neurons. PD, SN, UCPs
80  2019 Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe. LSD, MDMA, mPFC, NAc, PPI
81  2019 Neurochemical and neuroinflammatory perturbations in two Gulf War Illness models: Modulation by the immunotherapeutic LNFPIII. CORT, DEET, DFP, GW, GWI, LNFPIII, PB, PM
82  2019 Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease. ELISA, GDNF, GFAP, IBA1, MPTP, PD, SN, SNpc, TH, VTA
83  2019 NF-kappaB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols. NF-kappaB, PD
84  2019 NIPSNAP1 and NIPSNAP2 Act as "Eat Me" Signals for Mitophagy. NIPSNAP1
85  2019 Olfactory ensheathing cells improve the survival of porcine neural xenografts in a Parkinsonian rat model. hfVM, OECs, PD, pfVM
86  2019 One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders. iPSC, PD
87  2019 Parkin is transcriptionally regulated by the aryl hydrocarbon receptor: Impact on alpha-synuclein protein levels. AhR, PD, PRKN
88  2019 Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells. HDs, iPSCs, NTFs, PD, SN, TDNs
89  2019 Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and alpha-synuclein stability through membrane remodeling. alpha-Syn, ER, PD
90  2019 Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons. PD, SAPNS
91  2019 Peripheral nerve injury-induced alterations in VTA neuron firing properties. VTA
92  2019 Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis. ATM, PD, Prxs
93  2019 Poloxamer 188 rescues MPTP-induced lysosomal membrane integrity impairment in cellular and mouse models of Parkinson's disease. PD, SNpc
94  2019 Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus. DBS, PD, SNpc, STN
95  2019 Prenatal Ethanol Exposure and Postnatal Environmental Intervention Alter Dopaminergic Neuron and Microglia Morphology in the Ventral Tegmental Area During Adulthood. FASD, PE, VTA
96  2019 Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway. MMP, PC, PD, PI3K, SOD
97  2019 Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro. ---
98  2019 Robustness to Axon Initial Segment Variation Is Explained by Somatodendritic Excitability in Rat Substantia Nigra Dopaminergic Neurons. ABD, AIS, AP
99  2019 Role of gold nanoparticle from Cinnamomum verum against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mice model. IL-1beta, IL-6, MPTP, PD, TNF-alpha
100  2019 Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. PD, Sal